Unjha Formulations Ltd
₹31.50▲ +0.00 (+0.00%)
UNJHAFOR·BSE·Healthcare
Market Cap
13.97 Cr
PE Ratio
20.06
Volume
1,476
Day High - Low
31.50 - 30.00
52W High-Low
36.38 - 17.52
₹31.50▲ +0.00 (+0.00%)
Market Cap13.97 Cr
PE Ratio20.06
Volume1,476
Day High - Low31.50 - 30.00
52W High-Low36.38 - 17.52
Unjha Formulations Ltd (UNJHAFOR): company summary
The company's annual revenue rose 12.5% to ₹16 crore, but the latest quarter revenue fell 8.3% to ₹3 crore compared to the same quarter a year earlier.
Unjha Formulations Ltd (UNJHAFOR) is a micro-cap Healthcare company valued at ₹14 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Unjha Formulations Ltd last traded at ₹31.5, unchanged on the day.
- Recent developments
- On 2026-09-30, promoter holding was reported at 36.92%, with no changes in foreign institutional or domestic institutional holdings. In the latest quarter, the company reported net profit of ₹0 crore, down from ₹0 crore in the same quarter a year earlier, while revenue fell to ₹3 crore from ₹4 crore.
- Financial performance
- The company's annual revenue rose 12.5% to ₹16 crore, but the latest quarter revenue fell 8.3% to ₹3 crore compared to the same quarter a year earlier. Annual net profit surged 70.7% to ₹1 crore, while the latest quarter net profit was ₹0 crore, down 59.0% from the same quarter a year ago. The net profit margin improved to 4.5% from 2.9% in the prior year, and return on equity remained at 18.3%.
- Valuation multiples
- The stock trades at 20.1 times earnings, a discount to the Healthcare median of 32.0, 3.93 times book value.
- Things to watch
- The latest quarter revenue fell 8.3% compared to the same quarter a year earlier. The latest quarter net profit was ₹0 crore, down 59.0% from the same quarter a year ago. The stock is 13.4% below its 52-week high.
- Where it stands
- The company's annual revenue grew 12.5% to ₹16 crore, while annual net profit rose 70.7% to ₹1 crore. The latest quarter revenue fell 8.3% to ₹3 crore, and net profit was ₹0 crore, down 59.0% from the same quarter a year earlier. The stock is 13.4% below its 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
6.5/10
Fair
Fair Value
Sign in to see
ROE
18.34%
Strong
P/E
20.06x
Fair
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Fair
Price performance
Day₹30.00
₹31.50
52W₹17.52
₹36.38
DocStoX take
Supported by growth (8.0) and momentum (7.5), but held back by valuation (3.8).
DocStoX score
Low confidence6.5
/10
Fair
Quality
Solid
ROE 18.3%
Valuation
Rich
P/E 20.1×
Growth
Strong
Revenue +9.4% 5Y CAGR
Risk
Moderate
D/E 0.00
Momentum
Strong
74% of 52-week range
At a glance
Market Cap
₹14 Cr
52W High / Low
₹36 / ₹18
Dividend Yield
0.00%
Promoter Holding
36.92%
EPS (TTM)
₹1.57
Book Value
₹8.58
Key highlights
- Profit compounding 48% a year
- Low leverage — D/E 0.00
- Profitable in all of the last 5 years
- Small ₹14 cr company — thinner liquidity
4 Positives1 Watchout
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Unjha Formulations Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Unjha Formulations Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LLAURUS LABS LIMITEDZYDUS LIFESCIENCES LTDAPOLLO HOSPITALS ENTER. LCIPLA LTDDR. REDDY S LABORATORIESAUROBINDO PHARMA LTDMANKIND PHARMA LIMITEDLUPIN LIMITEDMANIPAL HEALTH ENTERPRI L
Compare Unjha Formulations Ltd with peers
Related tools & concepts
Value Unjha Formulations Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing